2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow HIV-2 Infection: new trials by email Literature Review of HIV-2 Infection trials Research Report on HIV-2 Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First-Line Treatment for HIV-2 Tenofovir + Emtricitabine or Lamivudine + Zidovudine, Tenofovir + Emtricitabine or Lamivudine + Lopinavir/ritonavir, Tenofovir + Emtricitabine or Lamivudine + Raltegravir - HIV-2 Infection | Phase 2 / Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 210 | 2016-01-26 | 2019-07-22 |
| Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients emtricitabine / tenofovir disoproxil fumarate / raltegravir . - HIV-2 Infection | Phase 2 | Completed | ANRS, Emerging Infectious Diseases | 30 | 2012-07-01 | 2026-04-02 |
Emtricitabine (2) · Raltegravir Potassium (2) · Tenofovir (2) · Lamivudine (1) · Lopinavir (1) · Ritonavir (1) · Zidovudine (1)
ANRS, Emerging Infectious Diseases (2)
Burkina Faso (1) · Côte d’Ivoire (1) · France (1) · Senegal (1) · Togo (1)